8-KFiled Aug 19, 8:00 PM ET

Cosmos Health Inc. Reports Q2 2026 Results, Record Revenue

$COSM · Cosmos Health Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

Cosmos Health Inc. Reports Q2 2026 Results, Record Revenue

What Happened
Cosmos Health Inc. announced its financial results for the quarter and six months ended June 30, 2026 in a press release dated August 19, 2026 (filed on Form 8-K on August 20, 2026). The company reported record revenue of $19.0 million for Q2 2026 and $36.9 million for the first half of 2026, and disclosed improved profitability and balance sheet metrics. The press release is included as Exhibit 99.1 to the Form 8-K.

Key Details

  • Q2 2026 revenue: $19.0 million (record quarter).
  • H1 2026 revenue: $36.9 million (record first half).
  • Q2 adjusted gross profit increased 58%.
  • Total liabilities reduced 13%; stockholders’ equity increased 12%.
  • Company announced a $5.0 million share repurchase program.

Why It Matters
The results show continued top-line growth (quarterly and year-to-date record revenue) alongside higher adjusted gross profit, indicating improving margins. The reduction in total liabilities and an increase in equity point to a stronger balance sheet. The $5M share repurchase program is a capital-allocation action that can reduce outstanding shares and return value to shareholders. Investors tracking earnings, revenue growth, profitability and capital return initiatives will view these items as the main takeaways from the 8-K.